Differential secretion of chicken growth hormone variants after growth hormone-releasing hormone stimulation in vitro.
Variants of growth hormone (GH) are present in most vertebrates. Chicken GH (cGH) undergoes posttranslational modifications that contribute to its structural diversity. Although the 22-kDa form of GH is the most abundant, some other variants have discrete bioactivities that may not be shared by others. The proportion of cGH variants changes during ontogeny, suggesting that they are regulated differentially. The effect of growth hormone-releasing hormone (GHRH) on the release of cGH variants was studied in both pituitary gland and primary cell cultures, employing sodium dodecyl sulfate polyacrylamide gel electrophoresis, Western blotting, and densitometry. GHRH (2 nM, 2 h) stimulated the secretion of most of the size variants of cGH although the amplitude of increase was not equal for each one. A differential effect on the secretion of GH size variants, particularly on the 22- (monomer) and 26-kDa (putatively glycosylated) cGH isoforms was found in both systems. In the whole pituitary culture, the proportion of the 26-kDa immunoreactive cGH increased 35% while the 22 kDa decreased 31% after GHRH treatment in comparison with the controls. In the primary cell culture system, the proportion of the glycosylated variant increased 43% whereas the monomer and the dimer decreased 22.26 and 29%, respectively, after GHRH stimulation. Activators of intracellular signals such as 1 mM 8-bromo-cAMP and 1 microM phorbol myristate acetate had a similar effect to that obtained with GHRH. The data support the hypothesis that GH variants may be under differential control and that GHRH promotes the release of a glycosylated cGH variant that has an extended half-life in circulation.
Martínez-Coria
Hilda
H
Department of Neuroendocrinology, Centro de Neurobiología, Universidad Nacional Autónoma de Mexico, Querétaro.
López-Rosales
L Javier
LJ
Carranza
Martha
M
Berumen
Laura
L
Luna
Maricela
M
Arámburo
Carlos
C
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western / Q000662:veterinary; D002478:Cells, Cultured; D002645:Chickens / Q000378:metabolism* / Q000502:physiology; D004591:Electrophoresis, Polyacrylamide Gel / Q000662:veterinary; D013006:Growth Hormone / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000378:metabolism / Q000494:pharmacology*; D007091:Image Processing, Computer-Assisted; D008297:Male; D009924:Organ Culture Techniques; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D020033:Protein Isoforms; D015398:Signal Transduction / Q000502:physiology; D013755:Tetradecanoylphorbol Acetate / Q000378:metabolism
D020033:Protein Isoforms; D015124:8-Bromo Cyclic Adenosine Monophosphate; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D013755:Tetradecanoylphorbol Acetate